Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more Onyx Pharmaceuticals, Inc. (MM) Charts. Click Here for more Onyx Pharmaceuticals, Inc. (MM) Charts.](/p.php?pid=staticchart&s=N%5EONXX&p=8&t=15)
Onyx Pharmaceuticals Announces Third Quarter 2004 Financial
Results Webcast and Teleconference
RICHMOND, Calif., Nov. 1 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc.
(NASDAQ:ONXX) today announced that it will webcast a teleconference discussing
its third quarter 2004 financial results on Thursday, November 4, 2004, at 5:00
p.m. Eastern Time (2:00 p.m. Pacific Time). Financial results for the third
quarter ended September 30, 2004 will be released earlier that day.
Interested parties may access a live webcast of the presentation at:
http://phx.corporate-ir.net/playerlink.zhtml?c=112065&s=wm&e=961508 or by
dialing 617-614-4911 and using the passcode 24169366. A replay of the
presentation will be available on the Onyx website or by dialing 617-801-6888
and using the passcode 92061130 approximately one hour after the teleconference
concludes. The replay will be available through December 4, 2004.
Onyx Pharmaceuticals is engaged in the development of novel cancer therapies
that target the molecular basis of cancer. With its collaborators, the company
is developing small molecule drugs, including BAY 43-9006 with Bayer
Pharmaceuticals Corporation. For more information about Onyx's pipeline and
activities, visit the company's website at http://www.onyx-pharm.com/.
DATASOURCE: Onyx Pharmaceuticals, Inc.
CONTACT: Julie Wood, +1-510-262-8757, or Alexandra Santos,
+1-510-243-3695, both for Onyx Pharmaceuticals, Inc.
Web site: http://www.onyx-pharm.com/